Microbot Medical Inc(MBOT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MBOT Microbot Medical Inc

Post-Market Trading 11-22 19:40:24 EST

0.9800

+0.0503

+5.41%

盘后0.9762

-0.0038-0.39%

17:02 EST

High0.9890	Low0.9114	Vol127.69K
Open0.9390	D1 Closing0.9297	Amplitude8.35%
Mkt Cap16.59M	Tradable Cap16.35M	Total Shares16.93M
T/O121.36K	T/O Rate0.77%	Tradable Shares16.68M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"MBOT","market":"US","secType":"STK","nameCN":"Microbot Medical Inc","latestPrice":0.98,"timestamp":1732309200000,"preClose":0.9297,"halted":0,"volume":127693,"hourTrading":{"tag":"盘后","latestPrice":0.9762,"preClose":0.98,"latestTime":"17:02 EST","volume":370,"amount":362.47320099999996,"timestamp":1732312922869},"delay":0,"floatShares":16684038,"shares":16932341,"eps":-0.783174,"marketStatus":"Post-Market Trading","change":0.0503,"latestTime":"11-22 19:40:24 EST","open":0.939,"high":0.989,"low":0.9114,"amount":121364.52598149,"amplitude":0.083468,"askPrice":0.9999,"askSize":5,"bidPrice":0.9762,"bidSize":22,"shortable":3,"etf":0,"ttmEps":-0.783174,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1732323600000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.9297,"preHourTrading":{"tag":"盘前","latestPrice":0.94,"preClose":0.9297,"latestTime":"08:50 EST","volume":134,"amount":125.036405,"timestamp":1732283433997},"postHourTrading":{"tag":"盘后","latestPrice":0.9762,"preClose":0.98,"latestTime":"17:02 EST","volume":370,"amount":362.47320099999996,"timestamp":1732312922869},"volumeRatio":1.290227,"impliedVol":1.5506,"impliedVolPercentile":0.5754},"requestUrl":"/m/hq/s/MBOT/wiki","defaultTab":"wiki","newsList":[{"id":"2483924488","title":"Microbot Medical Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2483924488","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483924488?lang=en_us&edition=fundamental","pubTime":"2024-11-14 12:07","pubTimestamp":1731557230,"startTime":"0","endTime":"0","summary":"Microbot Medical Inc reports results for the quarter ended September 30 - Earnings SummaryMicrobot Medical Inc MBOT.OQ reported a quarterly adjusted loss of 20 cents per share for the quarter ended Se","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL8N3ML093:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBOT"],"gpt_icon":0},{"id":"2482545096","title":"Microbot Medical Inc  expected to post a loss of 17 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2482545096","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482545096?lang=en_us&edition=fundamental","pubTime":"2024-11-09 06:53","pubTimestamp":1731106401,"startTime":"0","endTime":"0","summary":"Microbot Medical Inc  expected to post a loss of17cents a share - Earnings Preview Microbot Medical Inc MBOT.OQ MBOT.O is expected to show no change in quarterly revenue when it reports  results on No","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL8N3MF45N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBOT"],"gpt_icon":0},{"id":"2476972923","title":"Microbot Medical Stock Rises After Completing ACCESS-PVI Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2476972923","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476972923?lang=en_us&edition=fundamental","pubTime":"2024-10-17 00:22","pubTimestamp":1729095720,"startTime":"0","endTime":"0","summary":"Microbot Medical, Inc. MBOT has successfully completed patient enrollment and follow-up in its ACCESS-PVI human clinical trial, which evaluates the performance and safety of the LIBERTY Endovascular Robotic Surgical System in Peripheral Vascular Interventions.The company is now set to file its 510 submission with the FDA by the end of 2024 and plans to accelerate its go-to-market strategy upon clearance.Shares of MBOT have plunged 41.2% year to date against the industry’s 7.8% growth. The S&P 500 has risen 22.9% in the same time frame.Microbot Medical’s successful completion of the ACCESS-PVI clinical trial for the LIBERTY Endovascular Robotic Surgical System signals positive investor sentiment. The LIBERTY system's potential to revolutionize endovascular procedures by reducing costs, improving physician experience and enabling remote operations positions it as a groundbreaking advancement, driving positive price performance.Significance of MBOT's ACCESS-PVI Trial for LIBERTY System. L","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/U4GUduRjeOg4nMm.oXfQdA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1a9a38eb6d9cb218a416cc7ef77b5823","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/U4GUduRjeOg4nMm.oXfQdA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1a9a38eb6d9cb218a416cc7ef77b5823"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/microbot-medical-stock-rises-completing-162200257.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","LU2065731478.USD","BK4583","BK4082","BK4196","ADUS","BK4585","BK4588","LU1854104046.USD","PVI","LU1854103824.USD","MBOT","IE00BN0W2W23.USD","BK4567","DGX","RDNT"],"gpt_icon":0},{"id":"2475509274","title":"Microbot Medical Inc - Clinical Trial Results to Be Presented at Medical Conference in Early 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2475509274","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475509274?lang=en_us&edition=fundamental","pubTime":"2024-10-15 20:38","pubTimestamp":1728995880,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241015:nTUA3CHGWM:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBOT","BK4082"],"gpt_icon":0},{"id":"2475509213","title":"Microbot Medical Announces the Successful Completion of Its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of Liberty® During 2Q 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2475509213","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475509213?lang=en_us&edition=fundamental","pubTime":"2024-10-15 20:38","pubTimestamp":1728995880,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241015:nTUA3CHGWM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBOT","BK4082"],"gpt_icon":0},{"id":"2475092715","title":"Microbot Medical Inc - to File FDA 510(K) Submission by End of 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2475092715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475092715?lang=en_us&edition=fundamental","pubTime":"2024-10-15 20:38","pubTimestamp":1728995880,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241015:nTUA3CHGWM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBOT","BK4082"],"gpt_icon":0},{"id":"2475750904","title":"Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2475750904","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475750904?lang=en_us&edition=fundamental","pubTime":"2024-10-15 20:38","pubTimestamp":1728995880,"startTime":"0","endTime":"0","summary":"U.S. Food and Drug Administration (FDA) Submission Expected by end of 2024 Clinical Data to be Presented at Medical Conference in Early 2025 BRAINTREE, Mass., Oct.  15, 2024  (GLOBE NEWSWIRE) -- Micro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/15/2963230/0/en/Microbot-Medical-Announces-the-Successful-Completion-of-its-Pivotal-Human-Clinical-Trial-Accelerates-Go-to-Market-Strategy-to-Prepare-for-Commercial-Launch-of-LIBERTY-during-2Q-202.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBOT","BK4082"],"gpt_icon":0},{"id":"2471313381","title":"Microbot Medical Says it Expects to Finish its ACCESS-PVI Robotic Surgical System Clinical Trial Ahead of Schedule","url":"https://stock-news.laohu8.com/highlight/detail?id=2471313381","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2471313381?lang=en_us&edition=fundamental","pubTime":"2024-09-30 22:29","pubTimestamp":1727706560,"startTime":"0","endTime":"0","summary":"Microbot Medical  said Monday its expects to finish its ACCESS-PVI clinical trial ahead of schedule, and remains on track to file its 510 premarket medical device submission with the US Food and Drug Administration by the end of the year.With 80% of patients having completed follow-ups, Microbot's ACCESS-PVI clinical trial for the Liberty Endovascular Robotic Surgical System is experiencing faster-than-anticipated patient enrollment, the company said. The ACCESS-PVI clinical trial is a propspective multi-center, single-arm study evaluating its Liberty system's safety and performance in human subjects undergoing peripheral vascular interventions, in support of its premarket medical device submission to the FDA.The medical device company said it has completed all biocompatibility tests, as required by its Investigational Device Exemption application, and received full approval for the IDE study from the FDA. While conducting the clinical trial, the company has also received approval to c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MBOT","PVI","BK4082"],"gpt_icon":0},{"id":"2471324807","title":"BRIEF-Microbot Medical Accelerates Patient Enrollment Of Human Clinical Trial for LIBERTY","url":"https://stock-news.laohu8.com/highlight/detail?id=2471324807","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2471324807?lang=en_us&edition=fundamental","pubTime":"2024-09-30 20:48","pubTimestamp":1727700531,"startTime":"0","endTime":"0","summary":"Sept 30  - Microbot Medical Inc   :   * MICROBOT MEDICAL ACCELERATES PATIENT ENROLLMENT OF ITS PIVOTAL HUMAN CLINICAL TRIAL; EXPECTS TO COMPLETE THE TRIAL EARLIER THAN ANTICIPATED AS 80% OF PATIENTS HAVE COMPLETED FOLLOW UP   * MICROBOT MEDICAL INC - 80% OF PATIENTS COMPLETED FOLLOW-UP, TRIAL TO FINISH AHEAD OF SCHEDULE   * MICROBOT MEDICAL INC - ON TRACK FOR FDA 510 SUBMISSION BY END OF 2024Source text for Eikon:   Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["K","BK4585","BK4212","MBOT","BK4588","BK4082","BK4504"],"gpt_icon":0},{"id":"2471853802","title":"Microbot Medical Accelerates Patient Enrollment of Its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up","url":"https://stock-news.laohu8.com/highlight/detail?id=2471853802","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2471853802?lang=en_us&edition=fundamental","pubTime":"2024-09-30 20:30","pubTimestamp":1727699401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240930:nTUA4XDVHQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBOT","BK4082"],"gpt_icon":0},{"id":"2471802584","title":"Microbot Medical Inc - 80% of Patients Completed Follow-up, Trial to Finish Ahead of Schedule","url":"https://stock-news.laohu8.com/highlight/detail?id=2471802584","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2471802584?lang=en_us&edition=fundamental","pubTime":"2024-09-30 20:30","pubTimestamp":1727699401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240930:nTUA4XDVHQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBOT","BK4082"],"gpt_icon":0},{"id":"2471780258","title":"Microbot Medical Inc - on Track for FDA 510(K) Submission by End of 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2471780258","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2471780258?lang=en_us&edition=fundamental","pubTime":"2024-09-30 20:30","pubTimestamp":1727699401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240930:nTUA4XDVHQ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBOT","BK4082"],"gpt_icon":0},{"id":"2471802552","title":"Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up","url":"https://stock-news.laohu8.com/highlight/detail?id=2471802552","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2471802552?lang=en_us&edition=fundamental","pubTime":"2024-09-30 20:30","pubTimestamp":1727699400,"startTime":"0","endTime":"0","summary":"Confirms the Company on Track for FDA 510(k) Submission by end of 2024 Completes All IDE required Tests and Receives Final IDE Approval from the FDA for the ACCESS-PVI Study  BRAINTREE, Mass., Sept.  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/09/30/2955191/0/en/Microbot-Medical-Accelerates-Patient-Enrollment-of-its-Pivotal-Human-Clinical-Trial-Expects-to-Complete-the-Trial-Earlier-Than-Anticipated-as-80-of-Patients-Have-Completed-Follow-u.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","IDE","MBOT"],"gpt_icon":0},{"id":"2468356264","title":"Microbot Medical Announces the Successful Enrollment of 50% of the Patients in Its Pivotal Human Clinical Trial for the Liberty Endovascular Robotic Surgical System","url":"https://stock-news.laohu8.com/highlight/detail?id=2468356264","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468356264?lang=en_us&edition=fundamental","pubTime":"2024-09-17 20:30","pubTimestamp":1726576203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240917:nTUA78LQHF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBOT","BK4082"],"gpt_icon":0},{"id":"2468089356","title":"Microbot Medical Inc - to File 510(K) Submission With FDA by Year-End","url":"https://stock-news.laohu8.com/highlight/detail?id=2468089356","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468089356?lang=en_us&edition=fundamental","pubTime":"2024-09-17 20:30","pubTimestamp":1726576203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240917:nTUA78LQHF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","MBOT"],"gpt_icon":0},{"id":"2468359309","title":"Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System","url":"https://stock-news.laohu8.com/highlight/detail?id=2468359309","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468359309?lang=en_us&edition=fundamental","pubTime":"2024-09-17 20:30","pubTimestamp":1726576200,"startTime":"0","endTime":"0","summary":"Completion of enrollment expected in Q4 with FDA submission for commercialization anticipated by the end of 2024BRAINTREE, Mass., Sept.  17, 2024  (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MB","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/09/17/2947416/0/en/Microbot-Medical-Announces-the-Successful-Enrollment-of-50-of-the-Patients-in-its-Pivotal-Human-Clinical-Trial-for-the-LIBERTY-Endovascular-Robotic-Surgical-System.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBOT","BK4082"],"gpt_icon":0},{"id":"2461545664","title":"Microbot Medical (MBOT) Inks New Phase 2 Agreement for LIBERTY","url":"https://stock-news.laohu8.com/highlight/detail?id=2461545664","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2461545664?lang=en_us&edition=fundamental","pubTime":"2024-08-23 23:59","pubTimestamp":1724428740,"startTime":"0","endTime":"0","summary":"Microbot Medical Inc.MBOT recently announced a Phase 2 collaboration agreement with Corewell Health. Under the agreement, both companies will work together to develop the capabilities to perform simulated cardiovascular interventional procedures with LIBERTY — an endovascular robotic surgical system.The agreement followed the successful completion of Phase 1, which showed LIBERTY’s technical capabilities and outlined potential future applications in various endovascular interventions. Phase 1 evaluated the viability of LIBERTY as a remote telesurgery platform.For investors’ note, LIBERTY, an endovascular robotic surgical system, is designed to improve the way surgical robotics are being used in endovascular procedures by eliminating the need for large, cumbersome and expensive capital equipment, while reducing radiation exposure and physician strain.The latest partnership marks the continuation of Mirobot and Corewell Health's collaboration to advance remote telesurgery for endovascula","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/vZlajmbYZzKfSC9h66RaJg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ae98f9f4477af1de31a0a61cde692d41","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/vZlajmbYZzKfSC9h66RaJg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ae98f9f4477af1de31a0a61cde692d41"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/microbot-medical-mbot-inks-phase-155900305.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0079474960.USD","ISRG","BK4082","LU0823434740.USD","LU1854104046.USD","LU0122379950.USD","BK4548","LU1951200564.SGD","BK4196","BK4583","LU1974910355.USD","LU0823434583.USD","LU0354030511.USD","LU1917777945.USD","LU2265009873.SGD","LU1868837300.USD","TMDX","LU1951198990.SGD","LU2106854487.HKD","LU1983299246.USD","BK4534","LU1868836757.USD","LU0058720904.USD","LU1868836914.USD","BK4588","LU1804176565.USD","IE00B19Z9505.USD","BK4585","LU2023250504.SGD","LU1989764664.SGD","LU2023250843.SGD","BK4567","LU0823416689.USD","LU0354030438.USD","LU0061475181.USD","LU1023059063.AUD","LU0289739699.SGD","DGX","LU0097036916.USD","LU2324357040.USD","MBOT","LU2112291526.USD","LU1868836591.USD","BK4504","LU1061106388.HKD","LU1923623000.USD","LU1854103824.USD","LU0390134368.USD","LU1057294990.SGD","IE00B19Z8X17.USD"],"gpt_icon":0},{"id":"2461631470","title":"Microbot Medical Advances Telesurgery with Corewell Health Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2461631470","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2461631470?lang=en_us&edition=fundamental","pubTime":"2024-08-22 20:57","pubTimestamp":1724331464,"startTime":"0","endTime":"0","summary":"Microbot Medical (MBOT) just unveiled an announcement. Microbot Medical Inc. has announced a Phase 2 collaboration with Corewell HealthTM to push t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/microbot-medical-advances-telesurgery-with-corewell-health-collaboration?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/microbot-medical-advances-telesurgery-with-corewell-health-collaboration?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MBOT","BK4082"],"gpt_icon":0},{"id":"2461319955","title":"Microbot Medical Signs Phase 2 Collaboration Agreement With Corewell Health to Advance Remote Telesurgery Using the Liberty® Endovascular Robotic System","url":"https://stock-news.laohu8.com/highlight/detail?id=2461319955","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2461319955?lang=en_us&edition=fundamental","pubTime":"2024-08-22 20:30","pubTimestamp":1724329800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240822:nTUA3ZPKZG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","MBOT"],"gpt_icon":0},{"id":"2461531923","title":"Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System","url":"https://stock-news.laohu8.com/highlight/detail?id=2461531923","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2461531923?lang=en_us&edition=fundamental","pubTime":"2024-08-22 20:30","pubTimestamp":1724329800,"startTime":"0","endTime":"0","summary":"The agreement follows the successful completion of Phase 1 which evaluated the viability of LIBERTY as a remote telesurgery platform The objective of Phase 2 is to develop and demonstrate new telesurg","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/08/22/2934198/0/en/Microbot-Medical-Signs-Phase-2-Collaboration-Agreement-with-Corewell-Health-to-Advance-Remote-Telesurgery-Using-the-LIBERTY-Endovascular-Robotic-System.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBOT","BK4082"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.microbotmedical.com","stockEarnings":[{"period":"1week","weight":-0.0214},{"period":"1month","weight":-0.0658},{"period":"3month","weight":-0.079},{"period":"6month","weight":-0.0885},{"period":"1year","weight":-0.2957},{"period":"ytd","weight":-0.4331}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, a disposable robotic system for use in endovascular interventional procedures, such as cardiovascular, peripheral, and neurovascular; NovaCross, an intraluminal revascularization device; ViRob, an autonomous crawling micro-robot that cam crawl in various natural spaces within the human body, including blood vessels, the digestive tract and the respiratory system, as well as artificial spaces such as shunts, catheters, ports, etc.; TipCAT, a disposable self-propelled locomotive device for tubular anatomies; and One & Done platform. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.477513},{"month":2,"riseRate":0.125,"avgChangeRate":-0.005907},{"month":3,"riseRate":0.25,"avgChangeRate":-0.114452},{"month":4,"riseRate":0.375,"avgChangeRate":-0.038903},{"month":5,"riseRate":0.625,"avgChangeRate":0.022241},{"month":6,"riseRate":0.375,"avgChangeRate":-0.08932},{"month":7,"riseRate":0.25,"avgChangeRate":-0.010911},{"month":8,"riseRate":0.375,"avgChangeRate":-0.088498},{"month":9,"riseRate":0.375,"avgChangeRate":-0.044361},{"month":10,"riseRate":0.25,"avgChangeRate":-0.099503},{"month":11,"riseRate":0.625,"avgChangeRate":-0.068805},{"month":12,"riseRate":0.375,"avgChangeRate":0.117757}],"exchange":"NASDAQ","name":"Microbot Medical Inc","nameEN":"Microbot Medical Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Microbot Medical Inc(MBOT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Microbot Medical Inc(MBOT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Microbot Medical Inc,MBOT,Microbot Medical Inc股票,Microbot Medical Inc股票老虎,Microbot Medical Inc股票老虎国际,Microbot Medical Inc行情,Microbot Medical Inc股票行情,Microbot Medical Inc股价,Microbot Medical Inc股市,Microbot Medical Inc股票价格,Microbot Medical Inc股票交易,Microbot Medical Inc股票购买,Microbot Medical Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Microbot Medical Inc(MBOT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Microbot Medical Inc(MBOT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction